Trial intelligence / Profile preview

Modafinil Added to Clozapine in Schizophrenia

NCT00573417Phase 4Completed

Sponsor
North Suffolk Community Services
Start
Sep 2003
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Modafinil with Placebo (2 arms). Primary endpoint: Cognitive functioning at 8 weeks. Started Sep 2003; status: completed.

02

Drugs

modafinil
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT00573417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00573417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call